本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

17.48
-0.1640-0.93%
成交量:1.96萬
成交額:34.31萬
市值:22.34億
市盈率:101.36
高:17.59
開:17.55
低:17.48
收:17.64
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.43
換手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:6.04
市盈率(LYR):101.36

資料載入中...

2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

重要事件披露

Form 8-K - Current report
2025/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities